Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
For ANDAs, Pre-Submission Facility Correspondence Has Improved, But Still Not Ideal
Jul 20 2022
•
By
Derrick Gingery
The revised PFC program in GDUFA III is “still not anywhere near where we thought we were getting … but at least I think there’s some improvement,” Fresenius Kabi’s Molly Ventrelli said. • Source: Shutterstock
More from Generics
More from Biosimilars & Generics